Not Yet RecruitingPhase 3ACTRN12607000640404

Prospective trial of selective ultrasound-guided obturator nerve blockade for total knee replacement.

Prospective trial on efficacy of selective ultrasound-guided obturator nerve blockade for total knee replacement

Sponsor

Timothy Lee

Enrollment

40 participants

Start Date

Feb 1, 2008

Study Type

Interventional

Conditions

Patients undergoing unilateral total knee replacement.

Summary

Prospective trial of selective ultrasound-guided obturator block to determine its efficacy in providing analgesia following total knee joint replacement.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study investigates prospective trial of selective ultrasound-guided obturator nerve blockade for total knee replacement.. It is open to aged 18 and older. To join, participants should meet criteria including: undergoing unilateral total knee replacement.. People who have without preexisting lower limb neurological deficits.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Selective ultrasound-guided obturator nerve blockade performed preoperatively (using ropivacaine 37.5-75mg), in addition to continuous femoral nerve blockade (ropivacaine 75-150mg) and spinal anaesthesia (isobaric bupivacaine 15-20mg). Postoperative analgesia provided by femoral nerve local anaesthetic infusion (ropivacaine 16-24mg/hr), and morphine patient-controlled analgesia device (morphine 1mg bolus at 5min lockout).

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000640404